BioReliance (United States)

Recent papers from BioReliance (United States)

1. Complete genome sequences of four Ralstonia solanacearum phylotype IIB isolated from Musaceae plants in the PhilippinesMicrobiology Resource Announcements · 2026
2. Defining the levels of the chromatin landscape using the I-CATCH systemScientific Reports · 2026
3. Architecture as Program: Capability-Injected, Model-Driven Software Development in the Age of AI Agents2026
4. Leadless pacemaker implantation through the right internal jugular vein: primary results from the VAMPIRE prospective registryEP Europace · 2026
5. Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 TrialJournal of Clinical Oncology · 2026
6. Evaluating the impact of ionic strength on retention of minute virus of mice during small virus‐retentive filtrationBiotechnology Progress · 2026
7. Mechanically Activated Extraction of Bioactive Substances from Populus tremula L. Bark: Yield and Functional PropertiesFood Processing Techniques and Technology · 2026
8. Deregulatory Disclosure Regimes and Masked Absences in Fracking Chemical DataScience Technology & Human Values · 2025
9. The demolished pub that quickly flipped heritage protection law in the state of Victoria, AustraliadisP - The Planning Review · 2025
10. Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFAFrontiers in Immunology · 2025
11. 405 nm light microbicidal efficacy on Treponema pallidum spiked in ex vivo human plateletsScientific Reports · 2025
12. Current Opportunities for the Integration and Use of Artificial Intelligence and Machine Learning in Clinical Trials: Good Clinical Practice PerspectivesJournal of the Society for Clinical Data Management · 2025
13. Validation of a Next Generation Sequencing Method for adventitious agents detection in a live vaccine matrixBiologicals · 2025
14. Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 StudyJournal of Immunotherapy and Precision Oncology · 2025
15. Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialSignal Transduction and Targeted Therapy · 2024
16. Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease RegistryThe Journal of Rheumatology · 2024
17. Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung CancerJAMA Oncology · 2024
18. Stimuli-Responsive Polymer Actuator for Soft RoboticsPolymers · 2024
19. Phase I dose-escalation and cohort expansion study of the anti-BTLA antibody, tifcemalimab, in combination with toripalimab (anti-PD-1) in heavily pretreated patients (pts) with advanced malignancies.Journal of Clinical Oncology · 2024
20. The Safer Driver App Decreases Mobile Phone Induced Distracted Driving: Evidence From a Randomized Controlled TrialJournal of Road Safety · 2024